FdaApplication
NDA 208419
Identifiers
- fda_app_no: NDA208419
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2020-08-21 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PEMETREXED | PEMETREXED | 1GM/40ML (25MG/ML) | SOLUTION;INTRAVENOUS |
| PEMETREXED | PEMETREXED | 500MG/20ML (25MG/ML) | SOLUTION;INTRAVENOUS |
| PEMETREXED | PEMETREXED | 100MG/4ML (25MG/ML) | SOLUTION;INTRAVENOUS |
3 products